Recruiting Fabry Disease Studies in Seoul
About Fabry Disease Clinical Trials in Seoul
Fabry disease is a rare genetic disorder caused by deficiency of the enzyme alpha-galactosidase A, leading to accumulation of a fatty substance in cells. It can affect the heart, kidneys, and nervous system. Treatment includes enzyme replacement therapy and chaperone therapy.
There are currently 1 fabry disease clinical trials recruiting participants in Seoul, KOREA. These studies are seeking a combined 18 participants. Research is being sponsored by GC Biopharma Corp. Clinical trial participation is free and participants receive study-related medical care at no cost.
Fabry Disease Clinical Trials in Seoul — FAQ
Are there fabry disease clinical trials in Seoul?
Yes, there are 1 fabry disease clinical trials currently recruiting in Seoul, KOREA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Seoul?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Seoul research site will contact you about next steps.
Are clinical trials in Seoul free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Seoul studies also compensate for your time and travel.
What fabry disease treatments are being tested?
The 1 active trials in Seoul are testing new therapies including novel drugs, biologics, and treatment approaches for fabry disease.
Data updated March 2, 2026 from ClinicalTrials.gov